Correction From Source: HyperBaric Systems Changes Name to ``Human BioSystems''.Business Editors PALO ALTO, Calif.--(BUSINESS WIRE)--Nov. 13, 2002 HyperBaric hyperbaric /hy·per·bar·ic/ (-bar´ik) having greater than normal pressure or weight; said of gases under greater than atmospheric pressure, or of a solution of greater specific gravity than another used as a reference standard. Systems (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :HYRB) has officially changed its corporate name to Human BioSystems. The new bulletin board trading symbol Trading symbol See: Ticker symbol is (OTCBB:HBSC HBSc Honours Bachelor of Science (degree) HBSC Hermosa Beach Soccer Club (Los Angeles, CA) ). Dr. David Lucas, Chief Scientific Officer and COO said that the company was very happy that shareholders had agreed with the name change. "Human BioSystems is a more accurate description of our company's activities. The name HyperBaric Systems has caused some confusion since we developed technology that does not involve high pressures," he said. "The company does have a patent for a unique hyperbaric chamber hyperbaric chamber or decompression chamber or recompression chamber Sealed chamber supplying a high-pressure atmosphere primarily for medical therapy. Breathing air or oxygen at typically 1. which constituted our original process for preserving biological materials. However, since then we have expanded and developed our preservation technologies and methodologies to include liquid solutions and cold storage under atmospheric pressures." Human BioSystems is primarily focused on commercializing its proprietary extended preservation solutions and processes for platelets, the congealing component of blood. The company is also conducting a comprehensive research program at its Michigan Research Center to safely extend the shelf life of donor organs including kidneys, hearts, livers, lungs and pancreas. Dr. Luis Toledo, noted kidney transplant specialist and Chief Medical Officer for Human BioSystems directs the project. Human BioSystems president, Harry Masuda, said that the company name change was important at this time. "We are in the midst Adv. 1. in the midst - the middle or central part or point; "in the midst of the forest"; "could he walk out in the midst of his piece?" midmost of extremely vital studies and hope to expand these shortly," he said. "We believe our company is poised for tremendous growth and we have been planning the name change for more than a year. It is certainly easier to change our name now rather then later; before we start generating revenues and attain a more prominent presence in the industry." Human BioSystems is headquartered in Palo Alto, California “Palo Alto” redirects here. For other uses, see Palo Alto (disambiguation). Palo Alto (IPA: /ˌpæloʊˈʔæltoʊ/, from Spanish: palo: "stick" and alto: "high", i.e. with additional offices in San Ramon and Rancho Mirage California. The company also has offices and research facilities in Michigan and Russia. Certain statements contained herein are "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995). Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those discussed in filings made by the Company with the Securities and Exchange Commission. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion